Hemab Therapeutics Holdings, Inc. (COAG)
44.75
-2.51
(-5.31%)
USD |
NASDAQ |
Jul 29, 16:00
44.86
+0.12
(+0.26%)
After-Hours: 20:00
Hemab Therapeutics Holdings Price : 44.75 for July 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 29, 2026 | 48.78 | 48.85 | 43.98 | 44.75 | 517591.0 |
| Jul 28, 2026 | 50.85 | 50.85 | 45.11 | 47.26 | 430568.0 |
| Jul 27, 2026 | 47.78 | 50.75 | 45.80 | 50.39 | 386322.0 |
| Jul 24, 2026 | 45.78 | 49.11 | 43.05 | 47.31 | 779648.0 |
| Jul 23, 2026 | 49.14 | 49.90 | 45.64 | 45.83 | 536508.0 |
| Jul 22, 2026 | 47.77 | 49.44 | 47.26 | 49.23 | 240740.0 |
| Jul 21, 2026 | 49.19 | 50.76 | 47.46 | 48.28 | 376163.0 |
| Jul 20, 2026 | 50.28 | 52.14 | 47.06 | 49.39 | 568922.0 |
| Jul 17, 2026 | 43.58 | 50.11 | 43.26 | 49.29 | 320015.0 |
| Jul 16, 2026 | 43.31 | 45.27 | 42.81 | 44.53 | 394040.0 |
| Jul 15, 2026 | 42.23 | 44.15 | 39.65 | 43.32 | 307357.0 |
| Jul 14, 2026 | 38.83 | 43.92 | 38.36 | 43.31 | 323847.0 |
| Jul 13, 2026 | 38.39 | 42.03 | 37.99 | 39.51 | 370020.0 |
| Jul 10, 2026 | 37.21 | 38.36 | 34.98 | 38.03 | 210393.0 |
| Jul 09, 2026 | 34.00 | 38.45 | 33.57 | 37.20 | 313403.0 |
| Jul 08, 2026 | 31.39 | 35.49 | 30.74 | 33.89 | 347152.0 |
| Jul 07, 2026 | 29.92 | 32.19 | 29.54 | 31.49 | 162037.0 |
| Jul 06, 2026 | 31.31 | 32.04 | 29.61 | 29.97 | 618122.0 |
| Jul 02, 2026 | 32.51 | 33.21 | 30.32 | 31.00 | 251804.0 |
| Jul 01, 2026 | 36.17 | 37.09 | 32.40 | 32.50 | 228774.0 |
| Jun 30, 2026 | 36.63 | 38.22 | 35.11 | 36.73 | 321620.0 |
| Jun 29, 2026 | 32.44 | 38.86 | 31.42 | 36.73 | 362213.0 |
| Jun 26, 2026 | 27.56 | 33.18 | 27.56 | 32.37 | 329199.0 |
| Jun 25, 2026 | 28.90 | 29.76 | 27.47 | 27.72 | 126429.0 |
| Jun 24, 2026 | 29.15 | 30.90 | 27.69 | 28.76 | 134975.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Apogee Therapeutics, Inc. | 134.20 |
| Arrowhead Pharmaceuticals, Inc. | 86.22 |
| Oncolytics Biotech, Inc. | 0.7516 |
| Sangamo Therapeutics, Inc. | 0.0688 |
| Sarepta Therapeutics, Inc. | 15.54 |
Price Related Metrics
| Earnings Yield | -1.82% |
| Market Cap | 2.090B |